Related Experiment Video
Updated: Oct 9, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Five-year follow-up of new cases after a coeliac disease mass screening
Olof Sandström1, Fredrik Norström2, Annelie Carlsson3
1Department of Clinical Sciences, Paediatrics, Umea University, Umea, Sweden olof.sandstrom@umu.se.
Insights
Children with potential coeliac disease face a high risk of developing the condition. However, a negative screening test indicates a low likelihood of a future coeliac disease diagnosis in children.
Area of Science:
- Pediatric Gastroenterology
- Immunology
- Public Health Screening
Background:
- Coeliac disease screening in children identifies individuals at risk.
- Previous mass screening identified seropositive children, with many diagnosed via biopsy.
Purpose of the Study:
- To identify new coeliac disease cases in a screened population over 5 years.
- To assess conversion rates from potential coeliac disease and seronegative status.
Main Methods:
- Follow-up appointments with serological testing and endoscopy for seropositive children.
- Linking seronegative children to a national registry for diagnosed cases.
Main Results:
- 32% of children with potential coeliac disease converted to diagnosed coeliac disease.
- One new case was identified through the national registry in a child with type 1 diabetes.
Conclusions:
- Children with potential coeliac disease have a significant risk of developing the condition.
- Negative screening results in childhood are associated with a low risk of future clinical coeliac disease diagnosis.
Objective:
We previously performed a population-based mass screening of coeliac disease in children aged 12 years in two birth cohorts resulting in 296 seropositive children, of whom 242 were diagnosed with coeliac disease after duodenal biopsies. In this follow-up study, we wanted to identify new cases in the screening population that tested negative-either converting from potential coeliac disease (seropositive but normal duodenal mucosa) or converting from seronegative at screening to diagnosed coeliac disease.
Methods:
All seropositive children were invited to a follow-up appointment 5 years after the screening with renewed serological testing and recommended endoscopic investigation if seropositive. Seronegative children in the screening study (n=12 353) were linked to the National Swedish Childhood Coeliac Disease Register to find cases diagnosed in healthcare during the same period.
Results:
In total, 230 (77%) came to the follow-up appointment, including 34 of 39 with potential coeliac disease. Of these, 11 (32%) had converted to coeliac disease. One new case was found in the National Swedish Childhood Coeliac Disease Register who received the diagnosis through routine screening in children with type 1 diabetes.
Conclusions:
There is a high risk of conversion to coeliac disease among those with potential disease. However, a negative screening test was associated with a very low risk for a clinical diagnosis within a follow-up period of 5 years.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Longitudinal Research
Endoscopic Procedures III: Video Capsule Endoscopy

